Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05499520 · ClinicalTrials.gov registry record · NA
Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 2,591
- Enrollment target
NCT05499520 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 2,591 participants.
The verdict
NCT05499520, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,591 participants
- Enrollment target
Study Summary
Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support later adoption and implementation. The study team is utilizing formative research to design and pre-test anti-smoking messages and two national longitudinal online survey experiments.
Interventions
- OTHER Culturally Tailored Anti-Smoking Messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,591 participants |
| Start Date | 2022-09-21 |
| Est. Completion | 2023-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05499520
The ClinicalTrials.gov registry entry for NCT05499520 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,591 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Culturally Tailored Anti-Smoking Messages is the first listed.
NCT05499520 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05499520 about?
NCT05499520 is a clinical study titled "Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women". Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support late...
What is the current status of trial NCT05499520?
This trial is currently completed. It is a NA study. The enrollment target is 2,591 participants. The study started on 2022-09-21. Estimated completion is 2023-08-15.
What interventions are being tested in trial NCT05499520?
The interventions under investigation include: Culturally Tailored Anti-Smoking Messages (OTHER).
Who is sponsoring clinical trial NCT05499520?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.